ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0991850 | null | fat milk|milk fat | MILK FAT |
C0015677 | The glyceryl esters of a fatty acid, or of a mixture of fatty acids. They are generally odorless, colorless, and tasteless if pure, but they may be flavored according to origin. Fats are insoluble in water, soluble in most organic solvents. They occur in animal and vegetable tissue and are generally obtained by boiling or by extraction under pressure. They are important in the diet (DIETARY FATS) as a source of energy. (Grant & Hackh's Chemical Dictionary, 5th ed) | Fat (substance)|Fats|FAT|fat|Fat|fats | Fatty acid glycerol esters |
C0929301 | Glandular tissue in the BREAST of human that is under the influence of hormones such as ESTROGENS; PROGESTINS; and PROLACTIN. In WOMEN, after PARTURITION, the mammary glands secrete milk (MILK, HUMAN) for the nourishment of the young. | Mammary Glands|Gland, Human Mammary|mammary glands|GLAND, MAMMARY|Mammary|Set of lactiferous glands|Glandular structure of breast (body structure)|Mammary gland structure|Human Mammary Gland|Human Mammary Glands|Mammary Gland|Gland, Mammary|mammary gland|Glands, Human Mammary|Mammary gland, NOS|Glandular structure of breast|Mammary gland|mammary|Mammary Gland, Human|Glandula mammaria|breast tissues that produce milk|Glands, Mammary|Structure of mammary gland|MAMMARY GLAND|Mammary Glands, Human|Mammary glands|Structure of mammary gland (body structure) | Mammary gland |
C0183828 | A long thin piece of cloth or paper as used for binding or fastening. | tape|tapes|TAPE|biomedical tape|Tape | Biomedical tape |
C0026591 | Female parents, human or animal. | mothers|Maternal|mother|Mother|mothering|Mothers|Mother (person)|maternal|MOTHER|Mother, NOS|woman with children | Mother (person) |
C0052189 | A 6.6-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS; INTERMEDIATE-DENSITY LIPOPROTEINS; and HIGH-DENSITY LIPOPROTEINS. Apo C-I displaces APO E from lipoproteins, modulate their binding to receptors (RECEPTORS, LDL), and thereby decrease their clearance from plasma. Elevated Apo C-I levels are associated with HYPERLIPOPROTEINEMIA and ATHEROSCLEROSIS. | Apo C I|Apolipoprotein C-I|Apolipoprotein C I|Apo C-I|Apolipoprotein C-I (substance)|Apolipoprotein C1 | apolipoprotein C-I |
C0020443 | A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. | Elevated Cholesterol|HYPERCHOLESTEREMIA|Hypercholesterolemia (elevated plasma cholesterol)|high blood cholesterol level|hypercholesterolaemia|High Cholesterol Levels|Hypercholesterolemias|Hypercholesterolemia (disorder)|Elevated total cholesterol|Levels, High Cholesterol|Increased total cholesterol|Cholesterol Level, High|Elevated Cholesterols|Cholesterol, Elevated|High Cholesterol Level|Hypercholesterolaemia, NOS|Hypercholesterolemia|HYPERCHOLESTEROLEMIA|Hypercholesterolaemia|hypercholesteremia|Cholesterols, Elevated|hypercholesteraemia|Hypercholesteremia|HYPERCHOLESTEROLAEMIA|Hypercholesteremias|Hypercholesterolemia, NOS|High cholesterol|Cholesterol Levels, High|Level, High Cholesterol|hypercholesterolemia|elevated cholesterol | Hypercholesterolemia |
C1156212 | Repression of transcription by altering the structure of chromatin, e.g. by conversion of large regions of DNA into an inaccessible state often called heterochromatin. [GOC:mah, PMID:10219245] | chromatin-mediated silencing|chromatin-mediated maintenance of transcriptional inactivation|chromatin silencing|transcriptional gene silencing|TGS | chromatin silencing |
C0006098 | A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. | Radioisotope Brachytherapy|Brachytherapy - action (qualifier value)|Brachytherapy, Radioisotope|Brachytherapy|Brachytherapy, intracavitary|Contact radiation therapy procedure, NOS|radiation brachytherapy|brachytherapy|Internal Radiation Brachytherapy|BRACHYTHERAPY|Brachytherapy procedure, NOS|Brachytherapy - action|brachytherapies|Radiation Brachytherapy|Brachytherapy (procedure)|Radioisotope brachytherapy|Brachytherapy procedure|Curietherapy|implant radiation|Internal Radiation Therapy|Plesiotherapy radiation|Internal Radiation|Contact radiation therapy procedure|implants radiation|internal radiation | Brachytherapy |
C0009630 | A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures. | concanavalin|Concanavalin A|ConA|concanavalin a|Concanavalin A (substance)|cona|Con-A|concanavalin A | Concanavalin A |
C0682610 | Absorptive cells in the lining of the INTESTINAL MUCOSA. They are differentiated EPITHELIAL CELLS with apical MICROVILLI facing the intestinal lumen. Enterocytes are more abundant in the SMALL INTESTINE than in the LARGE INTESTINE. Their microvilli greatly increase the luminal surface area of the cell by 14- to 40 fold. | enterocyte|Enterocytes|Enterocyte|enterocytes | Enterocytes |
C0003077 | A genus of nematodes of the superfamily ASCARIDOIDEA. Its organisms are found in the stomachs of marine animals and birds. Human infection occurs by ingestion of raw fish that contain larvae. | ANISAKIS|anisakis|Anisaki|Anisakis, NOS|Anisakis|Anisakis (organism)|Genus: Anisakis|Anisakis sp.|Anisakis species | Genus Anisakis |
C0014939 | Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. | Estrogens|Estrogenic drug, NOS|Estrogen Receptor Agonists|Agents, Estrogenic|estrogenic preparation|estrogen products|oestrogens|Product containing estrogen (product)|Estrogen (substance)|Compounds, Estrogenic|Estrogenic Agents|Oestrogens|Estrogen|Estrogen preparation, NOS|Receptor Agonists, Estrogen|ESTROGENS|Therapeutic Estrogen|estrogens|Estrogen-containing product|oestrogen|oestrogen products|estrogen substance|Estrogen preparation|Oestrogen preparation, NOS|Estrogenic Compounds|Agonists, Estrogen Receptor|estrogen|ESTROGENIC PREPARATIONS|Estrogen, NOS|Oestrogen, NOS|Oestrogenic drug, NOS | estrogens |
C0032015 | Hormones secreted by the PITUITARY GLAND including those from the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), and the ill-defined intermediate lobe. Structurally, they include small peptides, proteins, and glycoproteins. They are under the regulation of neural signals (NEUROTRANSMITTERS) or neuroendocrine signals (HYPOTHALAMIC HORMONES) from the hypothalamus as well as feedback from their targets such as ADRENAL CORTEX HORMONES; ANDROGENS; ESTROGENS. | Pituitary hormone, NOS|pituitary hormone|pituitary hormones|Hormones, Pituitary|Pituitary hormones|Pituitary hormone|Pituitary Hormones|Pituitary Hormone|hypophysial hormone|Pituitary hormone (substance) | Pituitary Hormones |
C0037663 | A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. | Pituitary Growth Hormone|Growth hormone preparation|pituitary growth hormone|Somatotropin preparation|Growth Hormone|somatotropic hormone|Somatotropin-containing product|somatotrophin|growth hormones|Growth Hormone, Pituitary|somatotropin|STH|GH|Product containing somatotropin (medicinal product)|Somatotropin|growth hormone|Somatotropin (substance)|SOMATOTROPIN | Growth Hormone |
C0040165 | The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. | T4 preparation|l thyroxine|Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-|3,5,3'5' Tetraiodothyronine|Levothyroxine|T4 Thyroid Hormone|Thyroxine-containing product|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine|LT4|Product containing levothyroxine (medicinal product)|4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine|L-3,5,5'-tetraiodothyronine|3,5,3',5'-Tetraiodo-L-thyronine|3,5,3',5'-Tetraiodothyronine|Thyroxin|Tetraiodothyronine preparation|L-T4|Product containing thyroxine (medicinal product)|3,3',5,5'-Tetraiodo-L-thyronine|T>4<|O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine|Thyroid Hormone, T4|l-thyroxine|Thyroxine|3,5,3'5' tetraiodothyronine|LEVOTHYROXINE|Thyroxine (substance)|T<sub>4</sub>|O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine|thyroxine|T4|T4 - thyroxine|Thyroxine preparation|Levothyroxine (substance)|thyroxin|thyroxine (T4)|Levothyroxine-containing product|Levothyroxin|L-Thyroxine|levothyroxine | levothyroxine |
C0002903 | A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures. | Anesthesia|Administration of anesthesia|Anaesthesia procedure|anesthesias|anesthesia procedure|anesthesia procedures|anesthesia|anaesthesia|Administration of anaesthesia|Administration of anesthesia (procedure)|ANESTHESIA PROCEDURES|administration of anesthesia|Anesthesia Procedures|procedure anesthesia|Anesthesia procedure|GENERIC ANESTHESIA PROCEDURES|Anaesthesia procedure, NOS|Anesthesia procedure, NOS|Anesthesia Procedure | Anesthesia procedures |
C0961814 | Interleukin-22 (179 aa, ~20 kDa) is encoded by the human IL22 gene. This protein is involved in both cell signaling and the immune response. | IL-22|Interleukin-22|interleukin-22|Zcyto18|Cytokine Zcyto18|IL-10-Related T-Cell-Derived-Inducible Factor|IL-10-Related T-Cell-Derived Inducible Factor|IL-10-related T-cell-derived-inducible factor | interleukin-22 |
C0540333 | null | defensin, beta 4, human|defensin 4, human|defensin, beta 4A protein, human|DFB4 protein, human|hBD-2 antibacterial peptide|beta-defensin 104, human|beta-defensin 2, human|HBD4, human|hBD-2 protein, human|beta defensin 4, human|beta-defensin-2, human|DEFB4 protein, human|beta-defensin 4, human|hBD2 protein, human | DEFB4A protein, human |
C0079633 | A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells. | Interleukin-8 (IL-8)|CXCL8, Chemokine|Interleukin-8|Neutrophil-Activating Peptide, Anionic|Chemotactic Factor, Macrophage-Derived|AMCF-I|Interleukin 8|Chemotactic Factor, Neutrophil, Monocyte-Derived|Anionic Neutrophil Activating Peptide|Monocyte derived neutrophil chemotactic factor|Chemokine, CXCL8|CXCL8 Chemokine|Chemokine CXCL8|il8|Neutrophil Activating Peptide, Lymphocyte Derived|MDNCF|IL8|Interleukin-8 (substance)|Granulocyte Chemotactic Peptide-Interleukin-8|Neutrophil-Activating Peptide, Monocyte-Derived|CXCL8 Chemokines|Chemotactic Factor, Neutrophil|interleukin 8|Chemotactic Factor, Macrophage Derived|Monocyte-Derived Neutrophil Chemotactic Factor|Monocyte-Derived Neutrophil-Activating Peptide|Neutrophil Activating Peptide, Monocyte Derived|Neutrophil attractant/activating protein-1|Neutrophilic chemotactic factor|Lymphocyte-Derived Neutrophil-Activating Peptide|IL-8|interleukin-8|Granulocyte Chemotactic Peptide Interleukin 8|INTERLEUKIN-8|Neutrophil Activation Factor|Neutrophil Chemotactic Factor|Chemotactic Peptide-Interleukin-8, Granulocyte|Chemokines, CXCL8|Anionic Neutrophil-Activating Peptide|Macrophage-Derived Chemotactic Factor|il-8|NAP-1|Neutrophil-Activating Peptide, Lymphocyte-Derived|Alveolar Macrophage Chemotactic Factor I|Alveolar Macrophage Chemotactic Factor-I|Peptide, Anionic Neutrophil-Activating | interleukin-8 |
C0599755 | A group of individuals, identified by a common characteristic. | cohort|cohorting|cohorted|Cohort|cohorts | Cohort |
C0302193 | null | arterio venous|Artery and vein|arteri vein|vein artery|artery vein|artery veins|Arterio-venous|arteries veins | arterio-venous |
C0340685 | null | syndrome vibration|vibration syndrome|Vibration syndrome|Vibration disease|Vibration syndrome (disorder)|hand arm vibration syndrome|vibration disease | Vibration syndrome |
C0021212 | null | indicators|Indicators|indicator | Indicators |
C0282545 | A procedure for removal of the crystalline lens in cataract surgery in which an anterior capsulectomy is performed by means of a needle inserted through a small incision at the temporal limbus, allowing the lens contents to fall through the dilated pupil into the anterior chamber where they are broken up by the use of ultrasound and aspirated out of the eye through the incision. (Cline, et al., Dictionary of Visual Science, 4th ed & In Focus 1993;1(1):1) | Phacoemulsifications|phakoemulsification|Phacoemulsification|Phakoemulsification|phacoemulsification | Phacoemulsification |
C0523807 | The determination of oxygen-hemoglobin saturation of blood either by withdrawing a sample and passing it through a classical photoelectric oximeter or by electrodes attached to some translucent part of the body like finger, earlobe, or skin fold. It includes non-invasive oxygen monitoring by pulse oximetry. | o2 saturation|Oxygen saturation measurement (procedure)|Haemoglobin saturation measurement|Oximetry|oxygen saturation measurement|Hemoglobin saturation measurement|Oxygen saturation measurement|oxymetry|Oximetries|Hemoglobin Saturation|oxygen saturation|Oxygen Content Measurement|Oxygen Saturation|Blood Oxygen Saturation|Hemoglobin Saturation Measurement|oximetry|oxygen saturation level test|Oxygen Saturation Measurement|Oxygen content measurement|OXYSAT|oxygen saturation test|O2 Saturation|blood oxygen saturation|Oximetry (procedure) | Oxygen saturation measurement |
C0017185 | Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL. | Gastrointestinal tract neoplasm|Tumor of the Gastrointestinal System|gastrointestinal neoplasms|Gastrointestinal tract tumor|Tumor of GI System|Digestive System Tumor|gastrointestinal tumor|NEOPLASIA GI|Neoplasm of the gastrointestinal tract|Neoplasm of the Digestive System|Gastrointestinal System Tumor|Neoplasm of Digestive System|Neoplasm of GI System|GI Neoplasm|GI System Tumor|Neoplasm of Gastrointestinal System|Tumor of Digestive System|Digestive Neoplasm|Gastrointestinal System Neoplasm|Gastrointestinal Neoplasms|Gastrointestinal Tumor|GI NEOPLASIA|Neoplasms, Gastrointestinal|gut tumor|GASTROINTESTINAL TUMOR|Digestive System Neoplasm|Neoplasm of gastrointestinal tract|Tumor of the GI System|Tumour of gastrointestinal tract|Neoplasm, Gastrointestinal|Tumor of the Digestive System|Tumor of Gastrointestinal System|Neoplasm of the GI tract|Digestive Tumor|Gastrointestinal tract neoplasia|Tumor of gastrointestinal tract|gastrointestinal neoplasm|gastrointestinal tumors|GI System Neoplasm|Gastrointestinal Neoplasm|Neoplasm of the GI System|Neoplasm of the Gastrointestinal System|Neoplasm of gastrointestinal tract (disorder)|GI tract tumor|neoplasm of gastrointestinal tract|GI Tumor|gastrointestinal tract tumour | Gastrointestinal Neoplasms |
C0238301 | null | Nasopharynx Cancer|Cancer, Nasopharynx|Nasopharyngeal cancer|nasopharynx cancer|CA - Cancer of nasopharynx|Cancer of the Nasopharynx|nasopharyngeal cancer|Cancer of nasopharynx|Nasopharyngeal Cancers|Nasopharyngeal Cancer|Cancers, Nasopharynx|Cancer, Nasopharyngeal|Cancers, Nasopharyngeal|Nasopharynx Cancers|Cancer of Nasopharynx|Nasopharynx--Cancer | Cancer of Nasopharynx |
C1446041 | null | Serum protein profile (procedure) | Serum protein profile |
C0029923 | An albumin obtained from the white of eggs. It is a member of the serpin superfamily. | Ovalbumins|ovalbumin|Ovalbumin (substance)|OVALBUMIN|Ovalbumin|Serpin B14 | ovalbumin |
C0232462 | null | appetite poor|Reduced appetite|APPETITE DECREASED|Inappetence|appetite reducing|appetite decrease|Food appetite, decreased|reduced appetite|Poor appetite|Decreased appetite|Decrease in appetite (finding)|decrease appetite|Decreased food appetite|APPETITE DECREASE|POOR APPETITE|Hyporexia|appetites decrease|Decrease in appetite|decrease in appetite|poor appetite|appetite decreased|decreased appetite|appetite decreasing | Decrease in appetite |
C0596873 | The expansion of a lymphocyte population by cell division. [GOC:ai] | lymphocyte proliferation | lymphocyte proliferation |
C0600547 | A cinnamon-colored strain of Long-Evans rats which carries a mutation causing fulminant hepatitis and jaundice, with an associated gross accumulation of copper in the liver. This strain is a model for Wilson's Disease (see HEPATOLENTICULAR DEGENERATION). | Rats, Inbred Long-Evans Cinnamon|Rats, Long-Evans Cinnamon|Long-Evans Cinnamon Rats|Rats, Inbred Long Evans Cinnamon|Long Evans Cinnamon Rats|Cinnamon Rats, Long-Evans|Inbred LEC Rats|LEC Rat, Inbred|Inbred LEC Rat|LEC Rats, Inbred|Rat, Inbred LEC | Rats, Inbred LEC |
C0051083 | null | L-alanyl-L-proline|Ala-Pro|Alanylproline|L-Alanyl-L-proline|Alanylproline (substance) | alanylproline |
C0520886 | Evaluation of the interval from the end of ventricular depolarization to the onset of the T wave; it is usually isoelectric in normal subjects. | ekg st elevation|ST elevation|S-T segment elevated|st elevation ekg|ecg st elevation|Elevation, ST Segment|st elevation|elevated st segment|ST Segment Elevation|ECG ST ELEVATION|ST elevation (observable entity)|elevated st|elevations st|ST ELEVATION|ST ELEVATED|st segment elevation|elevation st|ST Segment Elevation by EKG Finding|ST SEGMENT ELEVATED|ST Segment Elevation by ECG Finding|ST segment elevation|ST segment elevation (finding)|ST Elevation|st segment elevated|st elevated | ST segment elevation (finding) |
C1533664 | null | Soave submucosal resection of rectum|Endorectal pull-through procedure|Endorectal resection|Soave operation, endorectal pull-through|Endorectal pull-through operation | Endorectal resection |
C0345245 | null | Hyperganglionosis (disorder) | Hyperganglionosis |
C0009806 | Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections. | Difficulty passing stool|Constipation|constipated|Unspecified Constipation|Difficult passing motion|CN - Constipation|Constipation, unspecified|Difficulty opening bowels|CONSTIPATION|Constipated|difficulty defecating|constipate|constipating|Difficulty defecating|Constipation (finding)|constipation|Costiveness|Difficulty defaecating | Constipation |
C0005220 | A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1. | beta-Galactosidase|lac Z Protein|beta D Galactosidase|beta-galactosidase|beta Galactosidases|BETA-D-GALACTOSIDASE|beta-Galactosidases|beta-D-Galactosidase|beta Galactosidase|beta-D-Galactoside galactohydrolase|beta-d-Galactosidase preparation|Beta-galactosidase-containing product|Protein, lac Z|Beta-galactosidase (substance)|Beta-galactosidase|beta galactosidase|Lactases|Product containing beta-galactosidase (medicinal product) | beta-Galactosidase |
C0005220 | A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1. | beta-Galactosidase|lac Z Protein|beta D Galactosidase|beta-galactosidase|beta Galactosidases|BETA-D-GALACTOSIDASE|beta-Galactosidases|beta-D-Galactosidase|beta Galactosidase|beta-D-Galactoside galactohydrolase|beta-d-Galactosidase preparation|Beta-galactosidase-containing product|Protein, lac Z|Beta-galactosidase (substance)|Beta-galactosidase|beta galactosidase|Lactases|Product containing beta-galactosidase (medicinal product) | beta-Galactosidase |
C0041194 | A salt-soluble precursor of elastin. Lysyl oxidase is instrumental in converting it to elastin in connective tissue. | Tropoelastin|tropoelastin | Tropoelastin |
C1272578 | null | Skin fibroblast|Skin fibroblast (cell)|fibroblasts skin|skin fibroblast | Skin fibroblast |
C0376437 | The excision of in-frame internal protein sequences (INTEINS) of a precursor protein, coupled with ligation of the flanking sequences (EXTEINS). Protein splicing is an autocatalytic reaction and results in the production of two proteins from a single primary translation product: the intein and the mature protein. | Splicings, Protein|Protein Splicings|Splicing, Protein|Protein Splicing|protein splicing | Protein Splicing |
C1136736 | The human male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in humans. | Y Chromosomes, Human|Human Y Chromosomes|Human Y Chromosome|Chromosomes, Human Y|Y Chromosome, Human|Chromosome, Human Y | Chromosomes, Human, Y |
C0043381 | The male sex chromosome, being the differential sex chromosome carried by half the male gametes and none of the female gametes in humans and in some other male-heterogametic species in which the homologue of the X chromosome has been retained. | y chromosomes|Y chromosome|Male sex chromosome|Y Chromosomes|chromosome male sex|chromosome y|Chromosome Y|chromosomes male sex|Sex chromosome Y|Y Chromosome|Sex chromosome Y (cell structure)|y chromosome|Chromosomes, Y|Chromosome, Y|chromosome sex y|male sex chromosome | Y Chromosome |
C0012984 | The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) | Canine, NOS|Canis canis|CANIS FAMILIARIS|dog|Mammals, Dogs|canine|Canine Species|Canine|Dogs|Canis familiaris|DOG|Canis lupus subspecies familiaris (organism)|Dog|Canis lupus subspecies familiaris|Domestic dog|Canis lupus familiaris|canines|Canis domesticus|dogs|Domestic dog ancestor|Canine species|CANINE SPECIES|domestic dog | Canis familiaris |
C0025800 | A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties. | N-Methyl-N-nitro-N-Nitrosoguanidine|1-Methyl-3-nitro-1-nitrosoguanidine|Methylnitrosonitroguanidine|NG|Guanidine, N-methyl-N'-nitro-N-nitroso-|MNG|Nitrosonitromethylguanidine|Methylnitronitrosoguanidine|N Methyl N' nitro N nitrosoguanidine|N-Methyl-N'-nitro-N-nitrosoguanidine|N'-nitro-N-nitroso-N-methylguanidine|N methyl N' nitro N nitrosoguanidine|Nitrosomethylnitroguanidine|MNNG | Methylnitronitrosoguanidine |
C0079866 | Process of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS. | mutagenesis|Mutageneses|Mutagenesis | Mutagenesis Process |
C1512710 | Any mutation that occurs in response to inducing agents, including radiation, viral infection, and a broad variety of mutagenic chemicals. | Induced Sequence Alteration|Induced DNA Alteration | Induced Mutation |
C0242958 | The products of chemical reactions that result in the addition of extraneous chemical groups to DNA. | adducts dna|DNA adducts|dna adduct|Adducts, DNA|dna adducts|Carcinogen-DNA Adducts|Drug-DNA Adduct|DNA Adduct | DNA Adducts |
C0069197 | An enzyme that transfers methyl groups from O(6)-methylguanine, and other methylated moieties of DNA, to a cysteine residue in itself, thus repairing alkylated DNA in a single-step reaction. EC 2.1.1.63. | alkylguanine DNA alkyltransferase|methylguanine DNA methyltransferase|O-6-Methylguanine-DNA Methyltransferase|DNA-6-O-methylguanine:protein-L-cysteine S-methyltransferase|Methylguanine-DNA Methyltransferase|O6-Alkylguanine DNA Alkyltransferase|Methylated DNA Protein Cysteine S Methyltransferase|O-6-Methylguanine-DNA-Alkyltransferase|O(6)-MeG-DNA Methyltransferase|O6-methylguanine-DNA methyltransferase (MGMT)|O(6)-Methylguanine Methyltransferase|EC 2.1.1.63|O(6)-Methylguanine-DNA Methyltransferase|Methylated-DNA-Protein-Cysteine S-Methyltransferase|Methylated-deoxyribonucleic acid-protein-cysteine methyltransferase (substance)|O(6)-AGT|mgmt|Methylated-DNA Protein-Cysteine Methyltransferase|Methylated-DNA-Protein-Cysteine Methyltransferase|O(6) alkylguanine DNA alkyltransferase|O-6-Methylguanine-DNA Alkyltransferase|MGMT|O(6)-Methylguanine DNA Transmethylase|Methylated-deoxyribonucleic acid-protein-cysteine methyltransferase|DNA-6-O-Methylguanine[protein]-L-Cysteine S-Methyltransferase|O(6)-Alkylguanine-DNA Alkyltransferase|Methylated-DNA-protein-cysteine methyltransferase|AGT|S-Methyltransferase, Methylated-DNA-Protein-Cysteine|Methylated-DNA--Protein-Cysteine Methyltransferase|guanine O(6) alkyltransferase|O(6) methylguanine DNA methyltransferase|Alkylguanine DNA Alkyltransferase|Guanine-O(6)-Alkyltransferase | O(6)-Methylguanine-DNA Methyltransferase |
C0085532 | Radiography of the vascular system of the heart muscle after injection of a contrast medium. | Angiography, coronary artery|artery coronary angiography|Coronary arteriography|coronary arteriogram|Angiography of coronary arteries|Coronary Angiographies|Coronary angiogram|angiogram coronary|coronary angiogram|Coronary arteriography, NOS|Coronary angiography|angiography coronary|coronary angiography|angiograms coronary|Angiographies, Coronary|CORONARY ANGIOGRAPHY|Coronary angiography (procedure)|Coronary angiography, NOS|Coronary arteriogram|coronary arteriography|Coronary arteriography NOS|coronariography|Coronary Angiography|Coronary angiogram, NOS|Angiography of coronary arteries, NOS|Angiography, Coronary|arteriogram coronary | Coronary angiography |
C0151744 | A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION). | myocardial ischemia/hypoxia|HEART, ISCHEMIC DISEASE|ihd|Ischemic heart disease, NOS|Ischemias, Myocardial|Ischemic heart disease NOS|Ischemic Heart Diseases|myocardial ischemia|IHD|Ischemic heart disease or syndrome|ISCHEMIA MYOCARDIAL|Diseases, Ischemic Heart|IHD - Ischemic heart disease|Ischemic Heart Diseases and Syndromes|Ischaemic heart disease, NOS|Cardiac ischemia|MYOCARDIAL ISCHEMIA|cardiac ischemia|Myocardial ischemia|Ischemic heart disease (disorder)|ischemic heart disease|Myocardial ischemia (disorder)|Myocardial Ischemia|myocardial ischaemia|Myocardial Ischemias|Ischemic heart disease|ISCHEMIC HEART DISEASES|Myocardial ischaemia, NOS|Ischaemic heart disease|Disease, Ischemic Heart|cardiac ischaemia|IHD - Ischaemic heart disease|Heart Disease, Ischemic|ischaemic heart disease|Ischemic Heart Disease|Ischemia, Myocardial|MYOCARDIAL ISCHAEMIA|Myocardial ischaemia|Heart Diseases, Ischemic|Myocardial ischemia, NOS|ISCHEMIC HEART DISEASE | Myocardial Ischemia |
C0063695 | A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. | Lymphocyte antigen CD54|ICAM1|ICAM-1|ICAM-1 - Intercellular adhesion molecule 1|Antigens, CD54|icam-1|icam1|Intercellular Adhesion Molecule-1|Antigen, CD54|Lymphocyte antigen CD54 (substance)|Cluster of differentiation antigen 54|CD54|CD54 (ICAM 1)|Intercellular adhesion molecule 1|Intercellular Adhesion Molecule 1|CD54 - Cluster of differentiation antigen 54|Glycoprotein ICAM 1 (human clone pHRVr1 deblocked protein moiety reduced)|CD54 Antigen|CD54 Antigens|cd54 | Intercellular adhesion molecule 1 |
C0063695 | A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. | Lymphocyte antigen CD54|ICAM1|ICAM-1|ICAM-1 - Intercellular adhesion molecule 1|Antigens, CD54|icam-1|icam1|Intercellular Adhesion Molecule-1|Antigen, CD54|Lymphocyte antigen CD54 (substance)|Cluster of differentiation antigen 54|CD54|CD54 (ICAM 1)|Intercellular adhesion molecule 1|Intercellular Adhesion Molecule 1|CD54 - Cluster of differentiation antigen 54|Glycoprotein ICAM 1 (human clone pHRVr1 deblocked protein moiety reduced)|CD54 Antigen|CD54 Antigens|cd54 | Intercellular adhesion molecule 1 |
C0004509 | A condition of having no sperm present in the ejaculate (SEMEN). | Azoospermia|Absent sperm in semen|azoospermia|azospermia|Sperm absent - azoospermia|AZOSPERMIA|Azoospermia (finding)|Spermatozoa absent|Azoospermatism|Azoospermia (disorder)|Sperm absent | Azoospermia |
C0028960 | A condition of suboptimal concentration of SPERMATOZOA in the ejaculated SEMEN to ensure successful FERTILIZATION of an OVUM. In humans, oligospermia is defined as a sperm count below 20 million per milliliter semen. | Low Sperm Counts|Oligoasthenoteratozoospermia|Oligoasthenoteratozoospermias|Oligozoospermia|Hypospermatogeneses|HYPOSPERMATOGENESIS|Low sperm count|oligozoospermia|oligospermia|Oligospermia|hypospermatogenesis|Sperm Counts, Low|OLIGOSPERMIA|Sperm Count, Low|Hypospermatogenesis|Low Sperm Count | Oligospermia |
C0042960 | Persons who donate their services. | Worker, Voluntary|Volunteer Worker|Volunteer helper (person)|Worker, Volunteer|Voluntary Workers|Volunteer Workers|Workers, Voluntary|volunteering|Voluntary helper|Volunteers|Volunteer helper|volunteers|Voluntary worker (person)|Voluntary Worker|Volunteer|Workers, Volunteer|volunteer|Voluntary worker|Voluntary helper (person) | Voluntary Workers |
C0438730 | null | Saliva specimen (specimen) | Saliva specimen |
C0340305 | MYOCARDIAL INFARCTION in which the inferior wall of the heart is involved. It is often caused by occlusion of the right coronary artery. | Diaphragmatic Myocardial Infarction|Myocardial Infarction, Inferior|MYOCARDIAL INFARCTION (INFERIOR WALL)|Inferior Myocardial Infarction|Diaphragmatic Myocardial Infarctions|inferior mi|Infarctions, Diaphragmatic Myocardial|mi inferior|inferior myocardial infarction|Infarction, Diaphragmatic Myocardial|Myocardial Infarctions, Diaphragmatic|Myocardial Infarction, Diaphragmatic|Inferior Wall Myocardial Infarction|Myocardial Infarction, Inferior Wall|imi|Inferior Myocardial Infarctions|Infarction, Inferior Myocardial|Myocardial Infarctions, Inferior|Infarctions, Inferior Myocardial | Inferior Wall Myocardial Infarction |
C0027054 | Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY. | Coronary Reperfusions|Reperfusions, Myocardial|myocardial reperfusion|Coronary Reperfusion Procedure|Reperfusion, Coronary|Coronary Reperfusion|Myocardial Reperfusions|Myocardial reperfusion|Reperfusions, Coronary|Reperfusion, Myocardial | Myocardial Reperfusion |
C0870074 | null | Infarction, inferior NOS | inferior infarction |
C0019145 | A branch of the celiac artery that distributes to the stomach, pancreas, duodenum, liver, gallbladder, and greater omentum. | Hepatic artery, NOS|Hepatic Artery|Hepatic artery (body structure)|HEPATIC ARTERY|hepatic arteri|Arteries, Hepatic|Hepatic Arteries|Artery, Hepatic|Hepatic artery|hepatic artery | Hepatic artery |
C1280126 | null | Entire common hepatic artery (body structure)|Entire common hepatic artery | Entire common hepatic artery |
C0940902 | null | Mucosal resection | mucosal resection |
C0079278 | Endoscopic examination, therapy or surgery of the gastrointestinal tract. | endoscopy digestive|Gastrointestinal tract examination|Gastrointestinal endoscopy|Endoscopies, Gastrointestinal|gastrointestinal endoscopy|endoscopy gastrointestinal|Endoscopy, Gastrointestinal|Digestive endoscopy|Endoscopy of GI tract|Gastrointestinal tract endoscopy|Gastrointestinal Endoscopy|digestive endoscopy|Gastrointestinal tract endoscopy (procedure)|Gastrointestinal Endoscopies | Endoscopy, Gastrointestinal |
C0227170 | A recess on each side in the wall of the HYPOPHARYNX. | Pyriform Sinus|Piriform Fossa|Structure of piriform recess|Sinus, Piriform|piriform sinus|pyriform sinus|Recess, Piriform|Piriform Sinus|Fossa, Piriform|Structure of piriform recess (body structure)|Piriform sinus|Recessus piriformis|Sinus, Pyriform|Piriform Recess|piriform recess|Pyriform sinus|Piriform recess|Piriform fossa|sinus piriform | Structure of piriform recess |
C0020676 | A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction. | Hypothyroidisms|Hypothyroidism (disorder)|Low T4|Underactive Thyroid|Hypothyroidism, NOS|THYROID ACTIVITY DECREASED|Unspecified acquired hypothyroidism|Hypothyroidism|Hypothyroid|HYPOTHYROIDISM|Unspecified hypothyroidism|hypothyroidisms|hypothyroid|hypothyroidism|Underactive thyroid|underactive thyroid | Hypothyroidism |
C0002913 | Procedure in which an anesthetic is injected into the epidural space. | Anesthesias, Extradural|Peridural anaesthesia|Epidural anaesthesia|LA - Local anesthetic epidural block|Peridural anesthesia|Peridural Anesthesia|Epidural Analgesia|Epidural, peridural anesthesia|peridural anaesthesia|Epidural anesthesia|peridural anesthesia|epidural block|Anesthesia, Epidural|Epidural Anesthesia|Epidural anesthesia (procedure)|Epidural block|LA - Local anaesthetic epidural block|epidural anaesthesia|Anesthesia, Extradural|Local anaesthetic epidural block|Extradural Anesthesia|Epidural Anesthesias|Anesthesia, Peridural|Peridural Anesthesias|Extradural block|Local anesthetic epidural block|Anesthesias, Epidural|Epidural Block|Extradural Anesthesias|Anesthesias, Peridural|epidural anesthesia | Epidural Anesthesia |
C0206058 | Surgery that may be scheduled or undertaken by choice. | Elective Surgical Procedure|Procedures, Elective Surgical|Surgical Procedure, Elective|Surgical Procedures, Elective|Elective Surgery|surgical procedures elective|Elective surgery|elective surgery|Optional surgery|Optional surgery (procedure)|Procedure, Elective Surgical|optional surgery|ELECTIVE|Surgery, Elective|Elective Surgical Procedures|elective surgeries | Elective Surgical Procedures |
C0853389 | null | postoperative pain relief|post operative analgesia|analgesia postoperative|analgesia post operative | postoperative analgesia |
C0191279 | null | Integumentary system incision (procedure)|incisions skin|INTEGUMENTARY SYSTEM: INCISIONS|Incision of skin|Integumentary system incision|Incision of skin, NOS|Incision of skin (procedure)|skin incision | Incision of skin |
C0018213 | Hyperthyroidism associated with diffuse hyperplasia of the thyroid gland (goiter), resulting from production of antibodies that are directed against the thyrotropin receptor complex of the follicular epithelial cells. As a result, the thyroid gland enlarges and secrets increased amounts of thyroid hormones. | Grave's disease|GOITER, EXOPHTHALMIC|Exophthalmic Goiters|Hyperthyroidism, Autoimmune|Disease, Graves|Morbus Basedow|basedows disease|Graves' disease|Graves' disease with exophthalmos|HYPERTHYROIDISM <GRAVES DISEASE>|HYPERTHYROIDISM GRAVES DISEASE|DISEASE GRAVES'|disease graves|hyperthyroidism graves disease|Graves' disease (disorder)|GOITER EXOPHTHALMIC|graves' disease|HYPERTHYROIDISM, AUTOIMMUNE|Toxic diffuse goiter with exophthalmos (disorder)|Graves Disease|FLAJANI DISEASE|Graves disease|graves disease|Exophthalmic Goiter|Exophthalmic goiter|Disease, Basedow|Basedow's disease|Goiters, Exophthalmic|Basedow's Disease|EXOPHTHALMIC GOITER|basedow's disease|Graves' Disease|GRAVES' DISEASE|Disease, Basedow's|Toxic diffuse goitre with exophthalmos|GRAVES DISEASE|BASEDOW DISEASE|Exophthalmic goitre|Basedow Disease|grave's disease|Goiter, Exophthalmic|basedow disease|Basedows Disease|exophthalmic goiter|diseases graves|EXOPHTHALMIC GOITRE|Basedow disease|Toxic diffuse goiter with exophthalmos|Disease, Graves' | Graves Disease |
C0040156 | A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING. | Thyrotoxicosis (disorder)|Thyrotoxicosis|Thyrotoxicosis, NOS|Thyrotoxicosis with or without goiter|Thyrotoxicosis with or without goitre|Thyrotoxicoses|Thyrotoxicosis with or without goiter (disorder)|Thyrotoxicosis NOS|THYROTOXICOSIS|thyrotoxicosis | Thyrotoxicosis |
C0303611 | One of the radioactive isotopes of technetium, a gamma/beta-emitter with a half life of 6 hours. | 99m-Tc|technetium-99m|TECHNETIUM TC-99M|99m, Technetium|Technetium TC-99m|TECHNETIUM Tc 99m|Product containing technetium-99m (medicinal product)|Technetium-99m-containing product|technetium tc 99m|technetium 99m|technetium TC-99m|Technetium-99m|TECHNETIUM,TC-99M|Tc 99m|Technetium 99m|Technetium-99m (substance)|99m technetium|TECHNETIUM (Tc 99m)|99m Technetium | technetium 99m |
C0040149 | Spontaneously remitting inflammatory condition of the THYROID GLAND, characterized by FEVER; MUSCLE WEAKNESS; SORE THROAT; severe thyroid PAIN; and an enlarged damaged gland containing GIANT CELLS. The disease frequently follows a viral infection. | Thyroiditis, Giant Cell|Giant cell thyroiditis,|Granulomatous Thyroiditis|de Quervain's thyroiditis|Subacute Nonsuppurative Thyroiditides|THYROIDITIS, PSEUDOTUBERCULOUS|Thyroiditis, De Quervain|THYROIDITIS, DE QUERVAIN|DeQuervain Thyroiditis|de quervain thyroiditis|Subacute Nonsuppurative Thyroiditis|De Quervain's thyroiditis|Subacute Painful Thyroiditis|Subacute granulomatous thyroiditis|Thyroiditis, Subacute|Subacute thyroiditis|subacute thyroiditis|De Quervain Thyroiditis|THYROIDITIS SUBACUTE|Thyroiditides, Giant Cell|Giant Cell Thyroiditides|Thyroiditides, Subacute Nonsuppurative|Thyroiditis, Subacute Painful|THYROIDITIS, SUBACUTE|Subacute Thyroiditides|Cell Thyroiditides, Giant|granulomatous thyroiditis|Subacute Granulomatous Thyroiditis|Subacute Painful Thyroiditides|Giant Cell Thyroiditis|Subacute Thyroiditis|Thyroiditides, Granulomatous|Thyroiditides, Subacute Painful|SUBACUTE THYROIDITIS|thyroiditis de quervain|Non-suppurative subacute thyroiditis|Painful Thyroiditis, Subacute|dequervain's thyroiditis|Nonsuppurative Thyroiditides, Subacute|Nonsuppurative Thyroiditis, Subacute|Giant cell thyroiditis|Cell Thyroiditis, Giant|Thyroiditides, Subacute|THYROIDITIS, GIANT CELL|Painful Thyroiditides, Subacute|Subacute thyroiditis (disorder)|Granulomatous Thyroiditides|de quervain's thyroiditis|Pseudogranulomatous thyroiditis|Granulomatous thyroiditis|de quervains thyroiditis|thyroiditis subacute|De Quervain's Thyroiditis|Thyroiditis, Granulomatous|Thyroiditis, Subacute Nonsuppurative|Subacute granulomatous thyroiditis (disorder) | Subacute thyroiditis |
C1148575 | Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen. [GOC:jl, ISBN:0198506732, ISBN:0721662544] | Antigen Binding|antigen binding | antigen binding |
C0040125 | Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones. | antithyroid preparations|thyroid antagonists|antithyroid agents|Drugs, Antithyroid|ANTITHYROID PREPARATIONS|antithyroid drugs|Antithyroid Drugs|Antithyroid Agents|Thyroid Antagonist|Antithyroid preparation, NOS|Medicinal product acting as antithyroid (product)|Antagonists, Thyroid|Antithyroid agent|inhibitors thyroid|antithyroid agent|Thyroid inhibitor|antithyroid drug|ANTITHYROID AGENTS|Thyroid antagonists|Antithyroid agent (substance)|thyroid inhibitor|Thyroid inhibitor preparation, NOS|Antithyroid Agent|Thyroid Antagonists|Agents, Antithyroid | Antithyroid Agents |
C0015528 | A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. | Transamidase, Factor XIII|factor xiii|laki lorand factor|Laki-Lorand Factor|Laki-Lorand factor|Blood-coagulation factor XIII|Blood Coagulation Factor XIII|fibrin stabilizing factor|Factor XIII Transamidase|Fibrinase|Factor Thirteen|Factor XIII|Coagulation factor XIII (substance)|Coagulation factor XIII|XIII, Coagulation Factor|Blood coagulation factor XIII|Product containing coagulation factor XIII (medicinal product)|Coagulation Factor XIII|Laki Lorand Factor|Laki Lorand factor|Fibrin stabilizing factor|factor XIII|Factor 13|Stabilizing Factor, Fibrin|coagulation factor XIII|Fibrin stabilising factor|FSF|fibrinase|Factor XIII, Coagulation|Coagulation factor XIII-containing product|Fibrin Stabilizing Factor | factor XIII |
C1281182 | null | Entire gastrointestinal tract (body structure)|Entire gastrointestinal tract | Entire gastrointestinal tract |
C0040691 | Hormonally active polypeptides that can induce the transformed phenotype when added to normal, non-transformed cells. They have been found in culture fluids from retrovirally transformed cells and in tumor-derived cells as well as in non-neoplastic sources. Their transforming activities are due to the simultaneous action of two otherwise unrelated factors, TRANSFORMING GROWTH FACTOR ALPHA and TRANSFORMING GROWTH FACTOR BETA. | Transforming Growth Factor|Growth Factor, Transforming|Factors, Transforming Growth|transforming growth factor|TGF|Transforming growth factors|Animal growth regulators, transforming growth factors|Factor, Transforming Growth|Transforming Growth Factors|Growth Factors, Transforming|Tumor Growth Factors|transforming growth factors | Transforming Growth Factors |
C0241950 | null | Bowel infarction|infarcts intestinal|intestinal infarction|Intestinal infarction|INTESTINAL INFARCTION | bowel infarction |
C0241950 | null | Bowel infarction|infarcts intestinal|intestinal infarction|Intestinal infarction|INTESTINAL INFARCTION | bowel infarction |
C0015528 | A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. | Transamidase, Factor XIII|factor xiii|laki lorand factor|Laki-Lorand Factor|Laki-Lorand factor|Blood-coagulation factor XIII|Blood Coagulation Factor XIII|fibrin stabilizing factor|Factor XIII Transamidase|Fibrinase|Factor Thirteen|Factor XIII|Coagulation factor XIII (substance)|Coagulation factor XIII|XIII, Coagulation Factor|Blood coagulation factor XIII|Product containing coagulation factor XIII (medicinal product)|Coagulation Factor XIII|Laki Lorand Factor|Laki Lorand factor|Fibrin stabilizing factor|factor XIII|Factor 13|Stabilizing Factor, Fibrin|coagulation factor XIII|Fibrin stabilising factor|FSF|fibrinase|Factor XIII, Coagulation|Coagulation factor XIII-containing product|Fibrin Stabilizing Factor | factor XIII |
C0524702 | null | Thromboembolisms, Pulmonary|Pulmonary thromboembolism|PTE - Pulmonary thromboembolism|PULMONARY THROMBOEMBOLISM|Pulmonary thromboembolism (disorder)|pulmonary thromboembolism|PE - Pulmonary thromboembolism|thromboembolism pulmonary|THROMBOEMBOLISM, PULMONARY|Thromboembolism, Pulmonary|Pulmonary Thromboembolism | Pulmonary Thromboembolisms |
C0015043 | An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. | Ethosuximidum|Etosuximida|(±)-2-ethyl-2-methylsuccinimide|3-methyl-3-ethylpyrrolidine-2,5-dione|Ethylmethylsuccimide|Product containing ethosuximide (medicinal product)|Aethosuximide|éthosuximide|Ethosuximide (substance)|3-ethyl-3-methylpyrrolidine-2,5-dione|α-ethyl-α-methylsuccinimide|ETHOSUXIMIDE|2-ethyl-2-methylsuccinimide|α-methyl-α-ethylsuccinimide|Ethosuccimid|3-ethyl-3-methylsuccinimide|Ethosuximid|γ-methyl-γ-ethyl-succinimide|Ethosuximide|2,5-Pyrrolidinedione, 3-ethyl-3-methyl-|3-Ethyl-3-methylpyrrolidine-2,5-dione|ethosuximide|2-methyl-2-ethylsuccinimide|3-methyl-3-ethylsuccinimide|γ-ethyl-γ-methyl-succinimide|Ethosuximide-containing product|3-ethyl-3-methyl-2,5-pyrrolidinedione | ethosuximide |
C0014553 | A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736) | EPILEPSY IDIOPATHIC PETIT MAL|EPILEPSY, PETIT MAL|PETIT MAL EPILEPSY|PRIMARY GENERALIZED EPILEPSY, MINOR|Simple absence|Absence Epilepsy|Petit-mal seizure|mals petit|seizures absence|Absences, typical|Absence, typical|Typical absence seizure|Epilepsy, Absence|petit mal epilepsy|PETIT MAL CONVULSION|absence epilepsy|Minor epilepsy|Petit mal epilepsy|Petit mal, typical|Typical absence seizures|absences epilepsy|absence seizures|Absence seizure|childhood absence epilepsy|EPILEPSY PETIT MAL|mal petit|Absence seizures|absence seizure|Typical absence seizure (disorder)|typical absence|mal petit seizure|Absence seizure (disorder)|petit mal seizure|EPILEPSY, MINOR|petit mal seizures|epilepsy absence|seizure petit mal|Petit Mal Epilepsy|Epilepsy, Petit Mal|absence seizure disorder|ABSENCE EPILEPSY|ABSENCE SEIZURE|CONVULSION PETIT MAL|petit mal|minor epilepsy|mal petit seizures|PETIT MAL|Petit mal | Absence Epilepsy |
C0206056 | A technique for measuring extracellular concentrations of substances in tissues, usually in vivo, by means of a small probe equipped with a semipermeable membrane. Substances may also be introduced into the extracellular space through the membrane. | Microdialysis|microdialysis | Microdialysis |
C0205127 | Running lengthwise. | longitudinal|Longitudinal|Longitudinal (qualifier value) | Longitudinal |
C0020731 | One of the virulence factors produced by BORDETELLA PERTUSSIS. It is a multimeric protein composed of five subunits S1 - S5. S1 contains mono ADPribose transferase activity. | Islets-Activating Protein|Lymphocytosis Promoting Factor|Lymphocytosis-Promoting Factor|Toxin, IAP Pertussis|Islets Activating Protein|Pertussis toxin|Islet-Activating Protein|Pertussis Toxin, IAP|Toxin, Pertussis|Histamine-Sensitizing Factor|IAP Pertussis Toxin|Pertussis Toxin|Histamine Sensitizing Factor|Islet Activating Protein|Pertussigen|pertussis toxin|Pertussis toxin (substance)|pertussigen | Pertussis Toxin |
C0455164 | An assisted fertilization technique consisting of the microinjection of a single viable sperm into an extracted ovum. It is used principally to overcome low sperm count, low sperm motility, inability of sperm to penetrate the egg, or other conditions related to male infertility (INFERTILITY, MALE). | IVF - In vitro fertilisation with intracytoplasmic sperm injection (ICSI)|Intracytoplasmic Sperm Injection|In vitro fertilisation with intra-cytoplasmic sperm injection|In vitro fertilisation with intracytoplasmic sperm injection|In vitro fertilization with intra-cytoplasmic sperm injection|In vitro fertilization with intracytoplasmic sperm injection (procedure)|intracytoplasmic sperm injection (ICSI)|Intracytoplasmic Sperm Injections|DISCO - direct inject of sperm into cytoplasm of oocyte|icsi|Sperm Injection, Intracytoplasmic|intracytoplasmic sperm injection|Injections, Sperm, Intracytoplasmic|ICSI|ICSI - intracytoplasmic sperm injection|Injection, Intracytoplasmic Sperm|IVF - In vitro fertilization with intracytoplasmic sperm injection (ICSI)|Injections, Intracytoplasmic Sperm|In vitro fertilization with intracytoplasmic sperm injection | Sperm Injections, Intracytoplasmic |
C0145745 | null | PDMP|DAMPP|threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol|2-decanoylamino-3-morpholino-1-phenylpropanol|1-phenyl-2-decanoylamino-3-morpholino-1-propanol | 1-phenyl-2-decanoylamino-3-morpholino-1-propanol |
C0016897 | A ganglioside present in abnormally large amounts in the brain and liver due to a deficient biosynthetic enzyme, G(M3):UDP-N-acetylgalactosaminyltransferase. Deficiency of this enzyme prevents the formation of G(M2) ganglioside from G(M3) ganglioside and is the cause of an anabolic sphingolipidosis. | GM3, Ganglioside|Haematoside|II3NeuAcLacCer|Hematoside|Sialyl Lactosylceramide|GM3-ganglioside|Lactosylceramide, Sialyl|Ganglioside GM3|Hematoside, NOS|GM3-ganglioside (substance)|Sialyllactosylceramide|Ganglioside GM3, NOS | G(M3) Ganglioside |
C0126732 | An I-kappa B protein that inhibits the activity of dimeric NF-KAPPA B P50-REL complexes, sequesters transcription factor NF-kappaB as an inactive complex in the cytoplasm; and prevents NF-kappaB nuclear translocation and DNA binding. | I Kappa B alpha Protein|Major Histocompatibility Complex Enhancer Binding Protein MAD3|Major Histocompatibility Complex Enhancer-Binding Protein MAD3|IKappaB-alpha|NF KappaB Inhibitor alpha|IKappaB alpha|IKappaBalpha|Inhibitor alpha, NF-KappaB|NF-KappaB Inhibitor alpha|p40 Protein (IKappaB-alpha)|I Kappa B-alpha Protein|alpha, NF-KappaB Inhibitor | NF-kappaB inhibitor alpha |
C0663914 | An enzyme complex that is involved in serine/threonine phosphorylation, inflammation and the regulation of the nuclear factor kappa-light-chain-enhancer of activated B cells protein complex. I-kappa-B kinase is comprised of three proteins, inhibitor of nuclear factor kappa-B kinase subunit alpha, beta and gamma. | I-Kappa-B Kinase|Kinase, IkappaB|IKK|IkappaB Kinase Complex|Nuclear Factor NFKappaB Inhibitor Kinase|B Kinase, I-kappa|Kinase, I-kappa B|Inhibitor of Nuclear Factor Kappa-B Kinase|I kappa B Kinase|NK kappa B Activating Kinase NAK|I-kappa B Kinase|NK-kappa B-Activating Kinase NAK|Nuclear Factor NF-Kappa-B Inhibitor Kinase|IkappaB Kinase|IKappaB Kinase | IkappaB kinase |
C0383881 | null | Ceramide, 1-O-(4-O-beta-D-galactopyranosyl-beta-glucopyranosyl)-|Cluster of differentiation antigen (workshop) 17|ceramide lactoside|lactosylceramide|Lactosylceramide|N-lignoceroyl-1-sphingosyl lactoside|CDw17 - Cluster of differentiation antigen (workshop) 17|Cluster of differentiation antigen (workshop) 17 (substance)|cytolipin H | CDw17 antigen |
C0016427 | Cyst due to the occlusion of the duct of a follicle or small gland. | Follicular cyst|Cysts, Follicular|cyst follicle|Cyst, follicular|Follicular Cyst|Follicle cyst|Follicular cyst, NOS|Cyst, Follicular|follicle cyst|Follicular cyst (morphologic abnormality)|follicular cyst|follicular cysts|Follicular Cysts | Follicular cyst |
C0029965 | The discharge of an OVUM from a rupturing follicle in the OVARY. | Ovulation, function|ovulation|Release of Egg|Ovulations|ovulates|Ovulation|Ovulation, function (observable entity)|ovulate|ovulations|Ovulated|ovulating | Ovulation |
C0037455 | Organizations composed of members with common interests and whose professions may be similar. | society [ organization]|society|Societies | Societies |
C1160267 | The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure. [GOC:go_curators] | ovarian follicle development | Ovarian follicle development |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.